Latest News on Pfizer Inc. (PFE) Stock

  • 23andMe Launches the Lupus Research Study in Collaboration with Pfizer Inc. [May 5 2015 11:22 AM]
  • 23andMe Launches the Lupus Research Study in Collaboration with Pfizer Inc.   MarketWatch - 14 hours ago MOUNTAIN VIEW, Calif., May 5, 2015 /PRNewswire/ -- 23andMe, Inc., the leading personal genetics company, today announced the launch of the Lupus Research Study in collaboration with Pfizer Inc. The companies aim to enroll 5,000 individuals with ... 23andMe, Pfizer jointly launch Lu... Read more about this Pfizer Inc. (PFE) news
  • Credit Suisse: We Prefer Pfizer, Bristol Over Pharma Peers [May 5 2015 05:56 AM]
  • Credit Suisse: We Prefer Pfizer, Bristol Over Pharma Peers   Benzinga - 19 hours ago Credit Suisse reviewed its stances on major U.S. pharma names in a note this week, though the analysts came to the same conclusion that Bristol-Myers Squibb Co (NYSE: BMY) and Pfizer Inc (NYSE: PFE) were the best in class. The analysts also noted that ... Top Credit Suisse Major Pharma Stock Picks to ... Read more about this Pfizer Inc. (PFE) news


  • One Put, One Call Option To Know About for Pfizer [May 4 2015 09:07 AM]
  • One Put, One Call Option To Know About for Pfizer   Forbes - May 4, 2015 So unless Pfizer Inc sees its shares decline 3.6% and the contract is exercised (resulting in a cost basis of $32.61 per share before broker commissions, subtracting the 39 cents from $33), the only upside to the put seller is from collecting that ... Read more about this Pfizer Inc. (PFE) news


  • Pfizer Inc. (PFE) China Sales Boosted As Viagra Gains Demand [May 4 2015 08:33 AM]
  • Pfizer Inc. (PFE) China Sales Boosted As Viagra Gains Demand   Bidness ETC - May 4, 2015 Pharmaceutical giant Pfizer Inc. (NYSE:PFE) continues to take full advantage of its erectile dysfunction (ED) drug Viagra, even as the drug reaches patent expiry in 2020. Pfizer Inc. (PFE) Sees Viagra Sales Rise Considerably In China - Business Finance News  Read more about this Pfizer Inc. (PFE) news
  • [$$] Zoetis Won’t Tame Pharma M&A [May 5 2015 09:30 PM]
  • [at The Wall Street Journal] - Despite antitrust considerations, Zoetis has signaled that more pharmaceuticals mergers are on the way. Read more about this Pfizer Inc. (PFE) news

Looking for Market Opportunties?


Today's Most Active Stocks
Today's Biggest Price % Gainers
Today's Biggest Price % Losers
Today's Unusual Rising Volume Stocks
Today's Unusual Falling Volume Stocks
Research Reports
Earning Calendar
ETF Center